OpRegen led to restoration of retinal tissue for 75% of patients with dry AMD and geographic atrophy who received the treatment across a wide area of atrophy. OpRegen, which consists of allogeneic retinal pigment epithelial (RPE) cells, led to restoration of retinal tissue for 3 out of 4 patients (75%) with dry age-related macular degeneration […]

Amgen has agreed to co-develop and co-commercialize with Kyowa Kirin its Phase III-bound KHK4083, a potentially first-in-class treatment for atopic dermatitis, through a collaboration that could generate more than $1.2 billion for the Japanese pharma—and expand its development into other autoimmune diseases. “Plans will be reviewed with global regulatory agencies later this year, with the […]

Big Danish biotech Genmab has signed on to a new collaboration, and it’s one both parties hope will tackle a broad swath of cancer indications. Genmab is partnering with Bolt Biotherapeutics out of Redwood City, CA, to develop up to three new antibody-based conjugates in oncology. In the deal, Genmab is paying Bolt $10 million […]